NASDAQ:CME - CME Group Stock Price, Price Target & More

CME Group trades on the NASDAQ under the ticker symbol "CME."

CME Group announced a quarterly dividend on Tuesday, May 8th. Stockholders of record on Friday, June 8th will be given a dividend of $0.70 per share on Monday, June 25th. This represents a $2.80 annualized dividend and a dividend yield of 1.64%. The ex-dividend date of this dividend is Thursday, June 7th. View CME Group's Dividend History.

CME Group Inc (NASDAQ:CME) released its quarterly earnings data on Thursday, April, 26th. The financial services provider reported $1.86 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.85 by $0.01. The financial services provider earned $1.10 billion during the quarter, compared to analyst estimates of $1.12 billion. CME Group had a return on equity of 8.48% and a net margin of 111.45%. CME Group's quarterly revenue was up 18.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.22 EPS. View CME Group's Earnings History.

CME Group is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for CME Group.

13 Wall Street analysts have issued 12 month price objectives for CME Group's shares. Their predictions range from $133.00 to $197.00. On average, they anticipate CME Group's stock price to reach $169.5385 in the next year. This suggests that the stock has a possible downside of 1.0%. View Analyst Ratings for CME Group.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to CME Group include Intercontinental Exchange (ICE), T. Rowe Price Group (TROW), DEUTSCHE BOERSE/ADR (DBOEY), Nasdaq (NDAQ), Cboe Global Markets (CBOE), LPL Financial (LPLA), BGC Partners (BGCP), INTL Fcstone (INTL), Yintech Investment (YIN), OTC Markets Group (OTCM), National (NHLD) and Primus Guaranty (PRSG).

Media stories about CME stock have been trending somewhat positive on Thursday, Accern reports. The research group rates the sentiment of media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. CME Group earned a news impact score of 0.20 on Accern's scale. They also gave media stories about the financial services provider an impact score of 44.76 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

CME Group's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Pendal Group Ltd (0.20%), KAMES CAPITAL plc (0.15%), Miller Howard Investments Inc. NY (0.13%), Bank of Montreal Can (0.12%), Gateway Investment Advisers LLC (0.07%) and Franklin Street Advisors Inc. NC (0.05%). Company insiders that own CME Group stock include Bryan T Durkin, Daniel R Glickman, Dennis Suskind, Derek Sammann, Hilda Harris Piell, Jack J Tobin, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kevin Kometer, Kimberly S Taylor, Leo Melamed, Martin J Gepsman, Phupinder Gill, Ronald A Pankau, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Institutional Ownership Trends for CME Group.

CME stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Pendal Group Ltd, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Clinton Group Inc., Nippon Life Global Investors Americas Inc., Nisa Investment Advisors LLC, Miller Howard Investments Inc. NY and Assenagon Asset Management S.A.. Company insiders that have sold CME Group company stock in the last year include Bryan T Durkin, Daniel R Glickman, Dennis Suskind, Derek Sammann, Hilda Harris Piell, Jack J Tobin, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kimberly S Taylor, Leo Melamed, Martin J Gepsman, Ronald A Pankau, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Insider Buying and Selling for CME Group.

CME stock was acquired by a variety of institutional investors in the last quarter, including KAMES CAPITAL plc, NN Investment Partners Holdings N.V., Westpac Banking Corp, State of Alaska Department of Revenue, Nadler Financial Group Inc., IFM Investors Pty Ltd, First United Bank Trust and DnB Asset Management AS. View Insider Buying and Selling for CME Group.

Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CME stock can currently be purchased for approximately $171.18.

CME Group has a market capitalization of $57.37 billion and generates $3.64 billion in revenue each year. The financial services provider earns $4.06 billion in net income (profit) each year or $4.77 on an earnings per share basis. CME Group employs 2,830 workers across the globe.

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at 312-930-1000 or via email at [email protected]